Does Natalizumab treat neuromyelitis optica?

Natalizumab is primarily used to treat multiple sclerosis (MS), not neuromyelitis optica (Optic Neuritis). Although neuromyelitis optica is commonly associated with multiple sclerosis, natalizumab is not a first-line treatment for neuromyelitis optica. Neuromyelitis optica is a demyelinating disease with the characteristics of relapse, remission, and relapse. The most commonly used first-line drug in treatment is glucocorticoids, which require high doses and short courses of treatment. For the treatment of neuromyelitis optica, steroid hormones are often used to reduce inflammation and relieve symptoms. If you are diagnosed with neuromyelitis optica, discuss the best treatment options with your doctor in detail.